UCSF Navigation Bar
UCSF Liver Center Home Page

Mini-Symposium Series

October 17, 2014 | Aldea Center on Mt. Sutro

Biliary Development and Disease

Presenters scheduled to appear:

Laura Bull, PhD | UCSF | Professor of Medicine/Gastroenterology

Stacey Huppert, PhD | University of Cincinnati | Associate Professor of Medicine/Gastroenterology

Keith Mostov, MD, PhD | UCSF | Professor of Anatomy – Biochemistry & Biophysics

Michael Pack, MD | University of Pennsylvania | Professor of Medicine/Gastroenterology

Phil Rosenthal, MD | UCSF |Professor of Medicine/Pediatrics-Gastroenterology

 

March 6, 2014 | Aldea Center on Mt. Sutro

 

Organ Fibrosis

Fibrosis is a repair mechanism found in many organs. Because severe fibrosis causes organ failure and promotes cancer, it is of clinical interest to understand how fibrosis develops and resolves. The Liver Center Mini-Symposium aims to advance fibrosis research by identifying commonalities in the cellular and molecular biology of fibrosis among different organs. 

Speakers Scheduled to Appear:

Tatiana Kisseleva, MD, PhD| UCSD | Associate Adjunct Professor of Medicine/Surgery

Origin and Fate of Fibrogenic Myofibroblasts

D. Montgomery Bissell, MD | UCSF | Professor of Medicine/Gastroenterology

Liver Fibrosis Treatment: Theory and Practice

Stephen Nishimura, MD | UCSF | Professor of Pathology

Selective Targeting of TGFbeta in Lung Disease

Nilgun Isik Reed, PhD | UCSF | Dean Sheppard Lab

Targeting Integrin-Mediated TGFbeta Activation to Treat Tissue Fibrosis

Valerie Weaver, PhD | UCSF | Professor of Surgery

Tissue Fibrosis: A Tense Situation

 

September 5, 2013 | 9am - 3pm Aldea Center on Mt. Sutro

 

At the Host/Virus Interface: Advances in Viral Hepatitis Research

Please join the Liver Center for the next Mini-Symposium focusing on viral hepatitis. This Mini-Symposium covers the most recent progress in hepatitis B and C research, including new insight into the role of microRNAs, the antiviral immune response and novel host factors required for efficient viral replication.

Speakers Scheduled to Appear:

Jody Baron, MD, PhD | UCSF | Associate Professor of Medicine - Gastroenterology | 9:10am-9:50am

Age-dependent hepatic lymphoid organization directs successful  immunity to hepatitis B

Brian Webster, PhD |  Gladstone Institute of Virology and Immunology | W. Greene Lab | 10:00am-10:20am

Overcoming superinfection exclusion in hepatitis C virus infection

Peter Sarnow, PhD | Stanford University | Professor of Microbiology and Immunology | 10:40am-11:20am

Roles for microRNA 122 in the hepatitis C virus life cycle

Holly Ramage, PhD | Gladstone Institute of Virology and Immunology | Melanie Ott Lab | 11:30-11:50am

A proteomics/genomics approach identifies novel proteins regulating Hepatitis C Virus infection

James C. Ryan, MD | UCSF | Associate Professor of Medicine - Gastroenterology | 1:00pm-1:40pm

Innate immunity and differential  outcomes of Hepatitis C

Glenn Randall, PhD | University of Chicago| Assistant Professor of Microbiology | 2:00pm-2:50pm

Home remodeling: Hepatitis C virus-host interactions

  

May 30, 2013 | 9am - 3pm Aldea Center on Mt. Sutro

Molecular Pathogenesis of Liver Cancers

 

Speakers Scheduled to Appear:

 

Xin Wang, PhD | National Cancer Institute | Chief, Liver Carcinogenesis Section

Insights into tumor heterogeneity and molecular pathogenesis of liver cancer

Erik Huntzicker, PhD | Genentech | Senior Research Associate

Notch2 inhibition enhances liver regeneration and impedes liver cancer

Julien Sage, PhD | Stanford | Associate Professor of Pediatrics and Genetics

Mechanisms of tumorigenesis in the liver upon loss of RB function

Andrei Goga, MD, PhD | UCSF | Associate Professor of Medicine | Hematology-Oncology

Oncogene signaling and therapeutics in mouse models of liver cancer

Vladislava Juric, PhD | UCSF | Postdoctoral Scholar | J. Michael Bishop Laboratory

 Oncogenes shape the nature of immune responses in tumors

John Gordan, MD, PhD | UCSF | Clinical Fellow | Medicine | Hematology-Oncology

 Metabolic effects on sensitivity to mTOR inhibition in hepatocellular carcinoma

 

January 24, 2013 | 9am - 3pm Aldea Center on Mt. Sutro

Of Mice and Men: The Pathology of Liver Disease

 

Speakers Scheduled to Appear:

 

Linda Ferrell, MD | UCSF | Professor of Medicine/Pathology

Pathology Update: Nonalcoholic fatty liver disease

Stewart Sell, MD | Wadsworth Center, University at Albany, SUNY | Professor

Comparison of cell lineage responses of rats and mice to liver injury and hepatocarcinogenesis

James P. Grenert, MD, PhD | UCSF | Associate Professor of Clinical Pathology

Benign or malignant?  Atypical hepatocellular neoplasms

Aras Mattis, MD, PhD - UCSF - Fellow | Liver and Gastro-intestinal Pathology

Human liver morphology in health and disease

Caroline Miller | M.Sc, DIC, AIBMS | Gladstone Institutes | Director, Histology and Light Microscopy Core

What the Gladstone Histology Core can do for your research

Directions to Aldea Center

 

February 28, 2012 | 9am-2:30pm Dolby Regeneration Medicine Building

Hepatic Lipid Metabolism in Health and Disease

 

Speakers Scheduled to Appear:

 

Charles Harris, MD, PhD | UCSF | Medicine/Endocrinology

Tryglyceride in Hepatic Steatosis: A Tale of Two DGATs

Ronald Krauss, MD | CHORI | Clinical Pharmacology & Experimental Therapeutics

Integrative Genomics for Identifying Determinants of Lipid Response to Statins

Andreas Stahl, PhD | UC Berkeley | Nutritional Sciences and Toxicology

Hepatic Fatty Acid Transporters

Jen-Chywan (Wally) Wang, PhD | UC Berkeley | Nutritional Sciences and Toxicology

Angiopoietin-like 4 (Angptl4) and Glucocorticoid-Regulated Lipid

Ethan Weiss, MD | UCSF | Medicine/Cardiology

Integrative Genomics for Identifying Determinants of Lipid Response to Statins

Top of Page

The University of California, San Francisco. ©2008 The Regents of the University of California

Web Development and Design by Dayspring Technologies, Inc.

UCSF home page UCSF home page About UCSF Search UCSF UCSF Medical Center